Join us for an insightful scientific webinar on advancements in sepsis management and reflections on the ADAPT Sepsis trial.
Join us for an insightful scientific webinar on "Advancements in Sepsis Management: Biomarker-Guided Antibiotic Therapy," where we will delve into the groundbreaking findings from the recent study on biomarker-guided antibiotic duration for patients with suspected sepsis. This study, conducted across multiple UK hospitals, explores the efficacy of using biomarkers such as Procalcitonin (PCT) and C-Reactive Protein (CRP) to guide the duration of antibiotic therapy in sepsis management.
Chair: Prof. Bronwen Connolly
Speaker: Prof. Paul Dark
Learning Objectives:
Vice Dean for Health and Care Partnerships, University of Manchester
Professor of Critical Care, Queen’s University Belfast
Bronwen Connolly is a critical care physiotherapist, and Senior Lecturer in Critical Care at Queen’s University Belfast. She is the Chief Investigator of the NIHR HTA-funded MARCH trial, investigating the effectiveness of mucoactive drugs in acute respiratory failure, and leads the development of a core outcome set for trials of physical rehabilitation in critical illness. Bronwen is the recipient of three previous NIHR Fellowships, and her research interests focus on acute respiratory and rehabilitation physiotherapy, the recovery, long-term outcome and survivorship of post critical illness patients, and clinical trial methodology around complex rehabilitation interventions. Bronwen sits on the NIHR Critical Care National Specialty Group and the UK Critical Care Research Group.
Vice Dean for Health and Care Partnerships, University of Manchester
Paul studied undergraduate physics and medicine. Graduating from The Manchester Medical School, he went on to study clinical academic surgery, emergency medicine and critical care at the Universities of Glasgow and Manchester in the UK, and at the Catholic University of Leuven, Belgium.
:
https://www.linkedin.com/in/paul-dark-33002722?lip
:
@https://x.com/darknatter